| 1 | MRNA | Moderna, Inc. | 8.48% |
| 2 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.21% |
| 3 | PRAX | Praxis Precision Medicines, Inc. | 6.13% |
| 4 | ILMN | Illumina, Inc. | 5.52% |
| 5 | GH | Guardant Health, Inc. | 5.18% |
| 6 | VRTX | Vertex Pharmaceuticals Incorporated | 4.61% |
| 7 | BMRN | BioMarin Pharmaceutical Inc. | 4.59% |
| 8 | NTRA | Natera, Inc. | 4.21% |
| 9 | TECH | Bio-Techne Corporation | 3.64% |
| 10 | BNTX | BioNTech SE | 3.58% |
| 11 | QGEN | Qiagen N.V. | 3.44% |
| 12 | CRSP | CRISPR Therapeutics AG | 3.08% |
| 13 | BMY | Bristol-Myers Squibb Company | 3.04% |
| 14 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.85% |
| 15 | TWST | Twist Bioscience Corporation | 2.54% |
| 16 | LON: AZN | AstraZeneca PLC | 2.53% |
| 17 | GILD | Gilead Sciences, Inc. | 2.50% |
| 18 | VCYT | Veracyte, Inc. | 2.38% |
| 19 | LLY | Eli Lilly and Company | 2.36% |
| 20 | LEGN | Legend Biotech Corporation | 2.34% |
| 21 | TXG | 10x Genomics, Inc. | 2.23% |
| 22 | BEAM | Beam Therapeutics Inc. | 2.04% |
| 23 | SRPT | Sarepta Therapeutics, Inc. | 1.92% |
| 24 | RARE | Ultragenyx Pharmaceutical Inc. | 1.76% |
| 25 | HKG: 1548 | Genscript Biotech Corporation | 1.60% |
| View GNOM holdings |
